Growth Metrics

Cme (CME) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $55.1 million.

  • Cme's Cost of Revenue fell 1155.7% to $55.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $253.0 million, marking a year-over-year decrease of 935.15%. This contributed to the annual value of $267.6 million for FY2024, which is 307.86% down from last year.
  • According to the latest figures from Q3 2025, Cme's Cost of Revenue is $55.1 million, which was down 1155.7% from $53.2 million recorded in Q2 2025.
  • Cme's 5-year Cost of Revenue high stood at $101.9 million for Q4 2023, and its period low was $43.9 million during Q3 2022.
  • In the last 5 years, Cme's Cost of Revenue had a median value of $56.5 million in 2023 and averaged $62.6 million.
  • In the last 5 years, Cme's Cost of Revenue tumbled by 3058.38% in 2021 and then soared by 2870.16% in 2023.
  • Cme's Cost of Revenue (Quarter) stood at $80.9 million in 2021, then grew by 17.43% to $95.0 million in 2022, then increased by 7.26% to $101.9 million in 2023, then decreased by 11.29% to $90.4 million in 2024, then plummeted by 39.05% to $55.1 million in 2025.
  • Its Cost of Revenue stands at $55.1 million for Q3 2025, versus $53.2 million for Q2 2025 and $54.3 million for Q1 2025.